C12N 2795/10123
Virus like particles [vlp]
Official title: Virus like particles [VLP]
C12N2795/10123 (Virus like particles [vlp]) appears on 9 US grants and 10 published applications in this corpus.
Search patents in C12N- Granted patents
- 9
- Published applications
- 10
- Assignees
- 3
- Inventors
- 19
- Latest grant
- 16 Jul 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 1 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 3 |
| 2015 | 2 | 1 |
| 2016 | 2 | 1 |
| 2017 | 1 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 1 | 1 |
| 2022 | 0 | 1 |
| 2023 | 1 | 1 |
| 2024 | 1 | 0 |
By publication year.
Recent patents
- Prokaryotic-eukaryotic hybrid viral vector for delivery of large cargos of genes and proteins into human cells16 Jul 2024US 12,037,597 B2The Catholic University of America
- Non-replicative transduction particles with one or more non-native tail fibers and transduction particle-based reporter systems7 Feb 2023US 11,572,595 B2Roche Molecular Systems, Inc.
- Prokaryotic-eukaryotic hybrid viral vector for delivery of large cargos of genes and proteins into human cells26 Oct 2021US 11,155,835 B2The Catholic University of America
- Designing a soluble full-length HIV-1 gp41 trimer11 Jul 2017US 9,701,722 B2The Catholic University of America
- Designing a soluble full-length HIV-1 gp41 trimer3 May 2016US 9,328,145 B2The Catholic University of America
- Non-replicative transduction particles with one or more non-native tail fibers and transduction particle-based reporter systems31 Aug 2023US 2023/0272491 A1Roche Molecular Systems, Inc.
- Prokaryotic-eukaryotic hybrid viral vector for delivery of large cargos of genes and proteins into human cells13 Jan 2022US 2022/0010335 A1The Catholic University of America
- Prokaryotic-eukaryotic hybrid viral vector for delivery of large cargos of genes and proteins into human cells25 Feb 2021US 2021/0054410 A1The Catholic University of America
- Non-replicative transduction particles with one or more non-native tail fibers and transduction particle-based reporter systems2 Jul 2020US 2020/0208226 A1Roche Molecular Systems, Inc.
- Designing a soluble full-length hiv-1 gp41 trimer21 Jul 2016US 2016/0207964 A1The Catholic University of America
Most cited
By later US patents
- Mutated and bacteriophage T4 nanoparticle arrayed F1-V immunogens from Yersinia pestis as next generation plague vaccines4US 9,328,149 B2The Catholic University of America · 2016
- Prokaryotic-eukaryotic hybrid viral vector for delivery of large cargos of genes and proteins into human cells2US 11,155,835 B2The Catholic University of America · 2021
- In vitro and in vivo delivery of genes and proteins using the bacteriophage T4 DNA packaging machine2US 9,163,262 B2The Catholic University of America · 2015
- Encapsidation of heterologous entities into virus-like particles1US 8,324,149 B2The Board of Trustees of the Leland Stanford Junior University · 2012
- In vitro and In vivo delivery of genes and proteins using the bacteriophage T4 DNA packaging machine1US 9,187,765 B2The Catholic University of America · 2015